Arthritis: all 3,555 studies

Page 7 of 36. Open to participants first (313), then studies with results posted, then the rest; newest registration first within each.

• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic ArthritisCompletedNCT02294227Phase 3Results posted
• A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)CompletedNCT02293902Phase 3Results posted
• A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisCompletedNCT02287922Phase 2Results posted
• A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid ArthritisCompletedNCT02287610Results posted
• A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee ArthroplastyCompletedNCT02284113Not applicableResults posted
• A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid ArthritisCompletedNCT02281552Phase 3Results posted
• Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint ArthroplastyCompletedNCT02276040Results posted
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)CompletedNCT02265705Phase 3Results posted
• A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis PatientsCompletedNCT02260791Phase 3Results posted
• Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid ArthritisCompletedNCT02252744Results posted
• Staying Positive With Arthritis StudyCompletedNCT02223858Not applicableResults posted
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).CompletedNCT02222493Phase 3Results posted
• Real Time 3D Imaging and Surrogate Bone ModelTerminatedNCT02204007Not applicableResults posted
• Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical PracticeCompletedNCT02202837Results posted
• A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) SubjectsCompletedNCT02198651Phase 4Results posted
• A Study of E6011 in Japanese Subjects With Rheumatoid ArthritisCompletedNCT02196558Phase 1/2Results posted
• An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With MethotrexateCompletedNCT02187055Phase 4Results posted
• Total Hip Arthroplasty Outcomes With Regional and Multimodal AnalgesiaCompletedNCT02186795Results posted
• A Study of Golimumab in Participants With Active Psoriatic ArthritisCompletedNCT02181673Phase 3Results posted
• Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee SystemTerminatedNCT02175576Not applicableResults posted
• A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT02167139Phase 3Results posted
• Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement SystemCompletedNCT02154516Not applicableResults posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid ArthritisCompletedNCT02151851Phase 3Results posted
• PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid ArthritisCompletedNCT02149121Phase 3Results posted
• A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background MethotrexateCompletedNCT02147587Phase 2Results posted
• A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCompletedNCT02141997Phase 2Results posted
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisCompletedNCT02137226Phase 3Results posted
• Depression and Anxiety in Rheumatoid ArthritisCompletedNCT02122406Results posted
• To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)CompletedNCT02121210Phase 3Results posted
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)CompletedNCT02115750Phase 3Results posted
• Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT02114931Phase 3Results posted
• A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa TherapiesCompletedNCT02097745Phase 3Results posted
• Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)CompletedNCT02094326Results posted
• Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)CompletedNCT02093026Phase 2Results posted
• Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-StudyTerminatedNCT02092961Phase 2Results posted
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisCompletedNCT02092467Phase 4Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF InhibitorCompletedNCT02079532Phase 3Results posted
• Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)CompletedNCT02072200Phase 4Results posted
• A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX AloneCompletedNCT02066389Phase 2Results posted
• Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis PatientsCompletedNCT02065713Phase 3Results posted
• Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis ParticipantsCompletedNCT02065700Phase 2Results posted
• Robotic Arm Assisted Total Knee ArthroplastyCompletedNCT02058069Not applicableResults posted
• To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisCompletedNCT02057250Phase 3Results posted
• An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid ArthritisCompletedNCT02049138Phase 2Results posted
• (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid ArthritisCompletedNCT02047604Phase 2Results posted
• A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)CompletedNCT02046616Phase 3Results posted
• A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic AgentCompletedNCT02046603Phase 3Results posted
• Personalized Risk Estimator for Rheumatoid Arthritis Family StudyCompletedNCT02046005Not applicableResults posted
• TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra TreatmentCompletedNCT02031471Phase 3Results posted
• TXA vs. Amicar in Total Knee and Hip ArthroplastyCompletedNCT02030821Phase 4Results posted
• ACTH Gel Therapy in Rheumatoid ArthritisCompletedNCT02030028Not applicableResults posted
• Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic ArthritisTerminatedNCT02029495Phase 3Results posted
• To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)CompletedNCT02028169Results posted
• Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic ArthritisCompletedNCT02024646Phase 3Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid ArthritisCompletedNCT02019472Phase 3Results posted
• Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT02015520Phase 2Results posted
• Evaluation Exparel Delivered in Knee ReplacementCompletedNCT02011464Phase 4Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme)CompletedNCT02010216Phase 4Results posted
• A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD TherapyCompletedNCT02006706Phase 3Results posted
• A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic TherapyCompletedNCT02001987Phase 3Results posted
• Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisTerminatedNCT01999192Phase 2Results posted
• A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid ArthritisCompletedNCT01995201Phase 3Results posted
• 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic ArthritisCompletedNCT01989468Phase 3Results posted
• Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisCompletedNCT01988103Phase 2Results posted
• A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.CompletedNCT01988012Phase 3Results posted
• A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid ArthritisCompletedNCT01987479Phase 3Results posted
• ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateTerminatedNCT01984268Phase 2Results posted
• Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or InfliximabCompletedNCT01981473Results posted
• Open-Label Extension Study Of Tofacitinib In Psoriatic ArthritisCompletedNCT01976364Phase 3Results posted
• AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) TreatmentCompletedNCT01973569Not applicableResults posted
• Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT01970475Phase 3Results posted
• Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.CompletedNCT01966718Phase 4Results posted
• A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)TerminatedNCT01962974Phase 3Results posted
• Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle PainCompletedNCT01961271Phase 4Results posted
• A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyCompletedNCT01960855Phase 2Results posted
• Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid ArthritisTerminatedNCT01955733Phase 3Results posted
• An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01951170Phase 3Results posted
• The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis PatientsCompletedNCT01948388Phase 4Results posted
• A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) ParticipantsCompletedNCT01941940Phase 3Results posted
• A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid ArthritisCompletedNCT01941095Phase 3Results posted
• A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01936181Phase 3Results posted
• Tofacitinib (Xeljanz) Special Investigation for Rheumatoid ArthritisCompletedNCT01932372Results posted
• Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to AdalimumabTerminatedNCT01927757Phase 4Results posted
• Safety and Efficacy Study of Apremilast to Treat Psoriatic ArthritisCompletedNCT01925768Phase 3Results posted
• A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)CompletedNCT01904279Phase 1Results posted
• Comparison of ARPE Prosthesis With the LiteratureCompletedNCT01904019Results posted
• Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject EtanerceptCompletedNCT01901185Phase 3Results posted
• A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT01895309Phase 3Results posted
• Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)CompletedNCT01894516Phase 2Results posted
• Extension Study up to 3 Years for Secukinumab in Psoriatic ArthritisCompletedNCT01892436Phase 3Results posted
• Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled SyringeCompletedNCT01890473Phase 1Results posted
• Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)CompletedNCT01888874Phase 2Results posted
• An Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT01885078Phase 3Results posted
• Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After SurgeryTerminatedNCT01884077Not applicableResults posted
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF InhibitorsCompletedNCT01882439Phase 3Results posted
• Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator StudyCompletedNCT01877668Phase 3Results posted
• Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in AustriaCompletedNCT01877239Results posted
• Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis PatientsCompletedNCT01876329Results posted

← Arthritis overview